Abstract
Objective. To investigate the impact of anxiety in development of psychovegetative syndrome in patients after operative myocardial revascularization, to describe the nature and direction of resulting autonomic dysfunction and to study the effect of treatment with anti-anxiety therapy for this condition.
Materials and methods. 54 patients aged 4575 (36 the main group, 18 the comparison group), on average 1112 days after the coronary artery bypass graft (CABG) and during the process of early and late postoperative rehabilitation were investigated. A score assessment of the psychological and autonomic spheres, and sleep quality was analyzed. Indicators of vegetative tone and vegetative regulation were assessed, in particular, temporal and spectral indicators of heart rate variability. In addition to basic therapy for ischemic heart disease (IHD), the patients of the main group received therapy with vegetative corrector.
Results. In most cases, in the early postoperative period after CABG, moderate anxiety disorders and sleep disturbance were registered in combination with autonomic dysregulation with sympathetic influences prevailing. Addition of psychotropic therapy to the basic therapy of IHD patients in the main group allowed for 1014 days to significantly reduce the level of anxiety, improve sleep quality and correct the existing autonomic disorders with a tendency to further regression in the late postoperative period.
Conclusions. This study found that patients with an increased level of anxiety after CABG are characterized by the formation of a psychovegetative syndrome with predominance of sympathetic activity. The use of anxiolytic therapy can reduce the severity of anxiety and autonomic dysfunction, which can probably become an additional factor contributing to successful rehabilitation of patients after CABG in the early and late postoperative periods and prevention of IHD progression.
Reference30 articles.
1. Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M-T., Corra U., Cosyns B., Deaton C., Graham I., Hall MS., Hobbs R., Løchen M-L., Löllgen H., Marques-Vidal P., Perk J., Presscott E., Redon J., Richter D.J., Sattar N., Smulders Y., Tiberi M., Bart van der Worp N.S.H., van Dis I., Verschuren W.M.M. European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical in Clinical Practice. European Heart Journal 2016; 252: 207–274.
2. Beljalov F.I. Depression, anxiety and stress in patients with ischemic heart disease. Terapevticheskii arkhiv. 2017; 8: 104–109 (in Russian).
3. Cristian D., Markus K., Joanna M. Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry 2009; 22 (1): 96–110.
4. Ibatov A.D. The influence of anxiety disorders on the course of coronary heart disease. Russian Medical Journal 2007; 20: 1443–1449 (in Russian).
5. Shvalev V.N. Pathological changes in the sympathetic division of the autonomic nervous system and cardiovascular pathology. Arkhiv patologii 1999; 3: 50–52 (in Russian).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献